Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER. | J Exp Ther Oncol;9(1): 17-25, 2011. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.

Zulehner, Nora; Maurer, Margarita; Wesierska-Gadek, Józefa.

Affiliation

Zulehner N; Cell Cycle Regulation Group, Division, Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.

J Exp Ther Oncol ; 9(1): 17-25, 2011.

Article in En | MEDLINE | ID: mdl-21275262

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / G1 Phase / G2 Phase / Cyclin-Dependent Kinases / Estrogen Receptor alpha Limits: Female / Humans Language: En Journal: J Exp Ther Oncol Journal subject: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / G1 Phase / G2 Phase / Cyclin-Dependent Kinases / Estrogen Receptor alpha Limits: Female / Humans Language: En Journal: J Exp Ther Oncol Journal subject: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Country of publication: